Fri, May 24, 2013, 1:24 AM EDT - U.S. Markets open in 8 hrs 6 mins
Treatment with Avastin was associated with an absolute risk reduction for 1-year death and 6-month progression as AVAiL trials showed. http://hemonctoday.com/article.aspx?rid=86070